SCHEMBL7736698

SCHEMBL7736698

[CH2]CC(Cl)(Cl)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
CYP1A2 P05177 2/20 0.41
KCNN4 O15554 4/20 0.38
ALDH1A1 P00352 2/20 0.38
TAAR1 Q96RJ0 1/20 0.36
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KIF11 P52732 4/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8379857 0.80 TSHR (0.46) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL1829396 0.76 TSHR (0.52) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL6062610 0.74 TAAR1 (0.52) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL6685341 0.74 TSHR (0.50) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL7409166 0.74 TSHR (0.50) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL8365376 0.74 TSHR (0.50) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL819164 0.74 TSHR (0.65) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL439212 0.72 KIF11 (0.46) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL2102354 0.72 TSHR (0.48) TSHRCYP1A2KCNN4ALDH1A1TAAR1
SCHEMBL11814132 0.72 TSHR (0.48) TSHRCYP1A2KCNN4ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1198456-A2 POTASSIUM CHANNEL OPENERS Abbott Laboratories (US) 2002-04-24 EP disclosed
WO-2001009096-A2 POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2001-02-08 WO disclosed
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
CN-1216986-A Isoxazole derivatives SANKYO CO (JP) 1999-05-19 CN disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed
EP-0193065-B1 Morpholine derivatives, processes for their production and their use as fungicides BASF AG (DE) 1995-08-23 EP disclosed
US-5376684-A Aminobutyric acid antagonist; antiepileptic agent CIBA-GEIGY CORPORATION (US) 1994-12-27 US disclosed
EP-0224163-B1 PROPYL AMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES BASF Aktiengesellschaft (DE) 1991-10-16 EP disclosed
US-4967003-A Propylamines, and their use as fungicides BASF AKTIENGESELLSCHAFT (DE) 1990-10-30 US disclosed
US-4758564-A Ether and thioether amines and their use as fungicides BASF AKTIENGESELLSCHAFT (DE) 1988-07-19 US disclosed
US-4732989-A INTERMEDIATES FOR BACTERICIDES G. D. SEARLE & CO. (US) 1988-03-22 US disclosed
EP-0224163-A2 Propyl amines, process for their preparation and their use as fungicides BASF Aktiengesellschaft (DE) 1987-06-03 EP disclosed
CN-86107151-A The dopamine-inhibitor 1987-05-13 CN disclosed
US-4661602-A ANTIANAEROBIC AGENTS G. D. SEARLE & CO. (US) 1987-04-28 US disclosed
EP-0193065-A1 Morpholine derivatives, processes for their production and their use as fungicides BASF Aktiengesellschaft (DE) 1986-09-03 EP disclosed